**NOTE: Memphis Actos attorney Darrell Castle is no longer accepting new Actos cases. We’ve kept the following information on our website for informational purposes only. If you would like to discuss another dangerous drug case, contact us today at 901-327-1212.**
The seventh Actos case out of thousands went to trial recently.
Frances Wisniewski, a 79-year old retired accountant, received a $2 million verdict. The jury found Actos contributed to Wisniewski’s bladder cancer.
This case follows a $9 billion verdict and is the second heavy-hitting verdict against Actos.
Actos Connection to Cancer Presented at Trial
Actos users claim Takeda, the manufacturer of the drug, either ignored or downplayed Actos’ cancer-causing risks. They claim the company knew the risks before it ever went on the market in the US.
At trial, attorneys presented evidence that Takeda officials even destroyed documents. That evidence exposed their knowledge of the risks during the development, marketing, and sales of Actos.
Most drugs come with side-effects, and some are more dangerous than others. To protect the public from injury, manufacturers must fully disclose all potential risks and side-effects. If the drug company fails to do so, especially if the company fails to do so intentionally, then the company should be held liable for the damages.
If you’ve taken Actos and developed bladder cancer, the dangerous drug attorneys at Darrell Castle & Associates would love to talk to you.
My firm has been investigating and following this drug very closely and have some of those thousands of cases awaiting trial. It’s not too late for you to file a lawsuit as well.
You need an attorney you can trust to fight for the compensation you need and deserve. Darrell Castle & Associates has received multiple Client Distinction Awards from Martindale-Hubbel for client satisfaction because we go that extra mile for your success.
Call (901) 327-1212 to schedule a FREE consultation with an experienced Memphis Actos attorney, or fill out the contact form on this page.